Chronic hepatitis C
Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C
6
Insulin resistance and steatosis in chronic hepatitis C
9
Vitamin D deficiency and vitamin D therapy in chronic hepatitis C
6
Module VPredictive factors for response to treatment of chronic hepatitis C
5
Serum lipids and chronic hepatitis C genotype 4: interaction and significance
10
Interferon based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C
10
Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients
5
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
10
Treatment of chronic hepatitis C virus infection in the near future
6
Side effects of medical therapy for chronic hepatitis C
7
Risk factors for liver fibrosis progression in patients with chronic hepatitis C
8
Chronic Hepatitis C Treatment with Direct Acting Antiviral Agents in a Real Life Setting
9
Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C
7
Direct Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
7
Long term changes in liver histology following treatment of chronic hepatitis C virus
10
Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy
9
Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C
9
Liver specific case fatality due to chronic hepatitis C virus infection: a systematic review
13
Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan
8
Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil the Brazilian Global Burden of Disease Study
8